Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
USANA Health ( (USNA) ) has shared an announcement.
On January 12, 2026, USANA Health Sciences announced that it expects fiscal 2025 consolidated net sales of about $925 million, modestly above its prior guidance of roughly $920 million, and issued an initial fiscal 2026 net sales outlook of $925 million to $1.0 billion ahead of its presentation at the 28th Annual ICR Conference in Orlando. The 2026 outlook assumes softer revenue in the core USANA nutritional business, with projected sales of $720 million to $765 million versus about $777 million in 2025, partially offset by anticipated growth at Hiya, which is forecast to rise to $140 million to $155 million from around $132 million, and at Rise Wellness, which is expected to accelerate sharply to $65 million to $80 million from approximately $16 million in 2025, even as the company invests heavily in inventory, capital expenditures and working capital and accepts breakeven operating margins at Rise Wellness to support early-stage expansion; management plans to update investors further when it reports fourth-quarter and full-year 2025 results on February 17, 2026, followed by an analyst conference call on February 18.
The most recent analyst rating on (USNA) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on USANA Health stock, see the USNA Stock Forecast page.
Spark’s Take on USNA Stock
According to Spark, TipRanks’ AI Analyst, USNA is a Neutral.
The score is held back primarily by compressed profitability and weaker cash generation despite strong revenue growth, with a technically weak setup (negative MACD and price below key moving averages) adding pressure. A very conservative, debt-free balance sheet and a mixed but constructive earnings narrative (comp plan engagement and venture growth vs softer sales and cost actions) provide partial support, while valuation is only moderate with no dividend yield provided.
To see Spark’s full report on USNA stock, click here.
More about USANA Health
USANA Health Sciences, Inc. is a global developer and manufacturer of high-quality nutritional supplements, functional foods and personal care products, which it sells directly to Brand Partners and Preferred Customers across North America, Europe, and the Asia-Pacific region. The company also holds a 78.8% controlling stake in children’s health and wellness company Hiya Health Products and owns Rise Wellness, whose brands include Rise Bar and Protein Pop, both focused on clean-label health products.
Average Trading Volume: 243,882
Technical Sentiment Signal: Sell
Current Market Cap: $365.8M
See more insights into USNA stock on TipRanks’ Stock Analysis page.